Commercialization of Biotechnology in the U'S'

1
THE UNIVERSITY OF TEXAS
SOUTHWESTERN MEDICAL CENTER
AT DALLAS
OFFICE FOR TECHNOLOGY DEVELOPMENT
DENNIS K. STONE, M.D.
CPRIT Subcommittee on Economic Development
Commercialization Meeting 2/11/09
2
Office for Technology Development UT Southwestern
Medical Center
Integrated Capabilities Industry recruits
Venture development, Licensing, Industrial
Partnering Successes Multiple start-ups
over 400 M raised Over 100 M in revenues in
past 8 years Industrial partnerships 6.4 M
project with Sanofi-Aventis 1.2 M project with
Ethicon 5 joint projects with Texas Instruments
CPRIT Subcommittee on Economic Development
Commercialization Meeting 2/11/09
3
Development Gap
Industrial partners and venture capital
are increasingly requiring advanced
technologies. Universities must take the
initiative to advance their own technologies to
the point where they can be commercialized. This
initiative will not be financed by venture.
CPRIT Subcommittee on Economic Development
Commercialization Meeting 2/11/09
4
Reata Therapeutics
UT Southwestern Startup Strategy in Practice
MONITOR PROJECT DEVELOPMENT
IDENTIFICATION OF CEO
BUSINESS PLAN
9/2002
1 M in OTDSUPPORT
TRAINED SCIENCE TEAM

ENGAGED POTENTIAL INVESTORS
CPRIT Subcommittee on Economic Development
Commercialization Meeting 2/11/09
5
Reata Therapeutics

• 110 M in financing
• Multiple clinical trials Lead in IIB
• Discovery platform for ND diseases
• 52 employees
• COOPERATIVE EFFORT UTSW MDA
• IMPORTING TECHNOLOGIES Dartmouth,
• NCI, New Zealand
• IMPORTING CAPITAL Korea, Singapore,
• Hong Kong, Indonesia Taiwan
• Model program 3 additional projects

CPRIT Subcommittee on Economic Development
Commercialization Meeting 2/11/09
6
CPRIT Subcommittee on Economic Development
Commercialization Meeting 2/11/09